The circadian transcriptional network is based on a competition between transcriptional activator and repressor complexes regulating the rhythmic expression of clock-controlled genes. We show here that the MYC-Associated factor X, MAX, plays a repressive role in this network and operates through its MYC-independent binding to E-box-containing regulatory regions within the promoters of circadian BMAL1 targets. This clock function of MAX is essential for maintaining a proper circadian rhythm but separated by the role of MAX as a partner of MYC in controlling cell proliferation. We also identified MAX Network Transcriptional repressor, MNT, as a fundamental partner of MAX-mediated circadian regulation. Collectively, our data indicate that MAX is an integral part of the core molecular clock and keeps the balance between positive and negative elements of the molecular clock machinery. Accordingly, alteration of MAX transcriptional complexes may contribute to circadian dysfunction in pathological contexts.
Introduction
Many cellular processes obey an endogenous cell-autonomous clock (the circadian clock) that has an intrinsic period of approximately 24 hours (Dibner et al., 2010; Reinke and Asher, 2019; Schibler and Sassone-Corsi, 2002) . The molecular mechanism underlying these circadian rhythms is based on the interconnected transcriptional-translational feedback loops where specific transcription factors repress the expression of their own target genes (Ercolani et al., 2015; Ko and Takahashi, 2006; Takahashi, 2017) .
Studies in cultured cells clearly showed the cell-autonomous feature of the transcriptional circadian rhythmicity and allowed the dissection of the molecular architecture of the clock (Lananna et al., 2018; Nagoshi et al., 2004) . Accordingly, the clock core network has been conceptualized as two transcriptional complexes operating in an antagonistic manner on the expression of clock-controlled genes (CCGs). On the one hand, the proteins CLOCK and BMAL1 interact to form a clock activator complex that stimulates the transcription of CCGs by recognizing E-box and Ebox-like cis-regulative elements proximal to their core promoters (Shearman et al., 2000) .
On the other hand, the association of PERIOD and CRYPTOCHROME proteins with CLOCK/BMAL1 forms a transcriptional repressor complex that decreases CLOCK/BMAL1dependent transcription (Cho et al., 2012; Van Der Horst et al., 1999; Vitaterna et al., 1999; Zheng et al., 2001) . The periodic competition between clock-activator and clockrepressor complexes determines the circadian expression of around 5-10% of the mammalian transcriptome (Buhr and Takahashi, 2013; Miller et al., 2007; Panda et al., 2002) . Nevertheless, additional negative regulators, such as REV-ERB nuclear receptors (Cho et al., 2012; Preitner et al., 2002) , appears important for a proper circadian rhythm and mathematical modelling of the circadian clock gene-regulatory network indicated that a synergy of multiple inhibitions are required for robust self-sustained oscillations (Pett et al., 2016) . In addition, a proper balance between activators and repressors of E-boxes has been proposed as a crucial requirement for generating circadian rhythms (Kim and Forger, 2012; Lee et al., 2011) .
Disruption of the molecular clock is associated with a variety of human pathologies, including cancer (Ercolani et al., 2015; Roenneberg and Merrow, 2016) . Ectopic overexpression of the oncogenic MYC protein has been recently reported to alter circadian gene expression in cancer cell lines, although the molecular mechanism behind this MYC function is still highly debated (Altman et al., 2017; Altman et al., 2015; Shostak et al., 2017; Shostak et al., 2016) .
MYC is a transcription factor that can either activate or repress transcription depending on the interacting protein partners (Alderton, 2014; Carroll et al., 2018) . As a heterodimer with the MYC-associated X-factor (MAX) protein, MYC stimulates transcription of diverse genes bearing promoter-proximal E-boxes, including important cell cycle and metabolic genes (Bretones et al., 2015; Wahlström and Henriksson, 2015) (Amati et al., 1992; Kretzner et al., 1992; Seoane et al., 2002) . However, MYC can also repress gene expression when recruited in complex with MIZ1 to non-E-box sites in the promoters of MIZ1 target genes (Gebhardt et al., 2006; Peukert et al., 1997; Wiese et al., 2013) .
Whether MYC-mediated alteration of the circadian rhythm depended on one or both mechanisms is still debated. Indeed, MYC overexpression was shown either to interfere with E-box driven transcription of the BMAL1-containing molecular clock complex (Altman et al., 2015) or to act as a direct transcriptional repressor of BMAL1 in an E-boxindependent fashion (Shostak et al., 2016) .
We report here that MAX operates as an unexpected integral and essential regulator of the circadian transcriptional network in a MYC-independent manner in both cancer and noncancerous cell lines. We further identified the MAX binding protein, MNT, as a fundamental component of MAX-mediated clock regulation. Our data also implies that circadian disruption upon ectopic MYC overexpression would depend on perturbation of a physiological repression operated by MAX/MNT complex.
Results
Knockdown of MAX represses the transcription of core clock genes in cancer cell lines Studies in U2OS cells over-expressing an ectopic MYC protein have shown that elevated levels of MYC can profoundly alter the expression of CLOCK/BMAL1-regulated genes (Altman et al., 2015; Shostak et al., 2016) . Since up-regulation of MYC has been reported in many triple negative breast cancer (TNBC) cells (Fallah et al., 2017) , we decided to evaluate whether this oncogene might control clock gene transcription in a TNBC cell line, MDA-MB-231. Thus, we compared mRNA levels of core clock genes in cells in which expression of BMAL1, MYC or MAX were knocked down by siRNA. In line with the dual role of the BMAL1-containing circadian complex in transcriptional regulation and with observations in Bmal1 -/mice (Kondratov et al., 2006) (Hatanaka et al., 2010) , the knockdown of BMAL1 reduced the levels of some clock transcripts (PER1, NR1D1, NR1D2 and TEF) while de-repressed PER2, CRY1 and CRY2 transcription (Fig. 1A) . Conversely, the expression of characterized MYC target genes involved in cell proliferation (Bretones et al., 2015) , such as CDK4, CDC25C, RCF4, NCL and MCM2, showed negligible differences in BMAL1-silenced cells compared with control cells (Fig. 1A) .
While knockdown of MYC markedly reduced mRNA levels of MYC proliferative-related targets, it had negligible effects on BMAL1-regulated genes (Fig. 1B) . Strikingly, cells with knocked down MAX showed drastic alterations in diverse clock transcripts (Fig. 1C) .
Indeed, the majority of core clock genes were significantly up-regulated upon MAX silencing, including the repressor genes, PER1, PER2, CRY1 and CRY2 (Fig. 1C) .
Notably, the decline of MAX in MAX-silenced cells was not sufficient for significantly influencing proliferative MYC targets, suggesting that the remaining MAX protein could still ensure a proper function of the MAX/MYC complex.
In line with our transcriptional data, knockdown of either MAX or BMAL1 had no effect on cell proliferation, while MYC-silenced MDA-MB-231 cells showed significantly reduced growth compared with control cells (Fig. 1D ). Immunoblot analysis in MDA-MB-231silenced cells confirmed that reduction of either BMAL1 or MAX elevated PER2, CRY1 and CRY2 protein levels, whereas knockdown of MYC had no such effect ( Fig. 1E ). Consistent with the observation that only MYC silencing influenced MDA-MB-231 proliferation, protein levels of the cell cycle regulator Cyclin Dependent Kinase Inhibitor 1A (CDKN1A, also known as p21) showed differences solely in MYC-silenced cells ( Fig. 1E ).
Knockdown of MAX expression by using two additional diverse and non-redundant siRNA sequences against MAX transcripts similarly affected BMAL1, PER1, PER2, CRY1, CRY2, and TEF transcript levels ( Fig. S1 ), thus ruling out that altered clock gene expression in MAX-silenced cells derived from off-target effects.
Notably, the knockdown of MAX significantly increased the expression of clock genes in a different TNBC cell line, BT549, as well as in cancer cell lines originated from skin (A375), stomach (SNU16) and liver (HEPG2) tumors ( Fig. 1F ), thus indicating that MAX-mediated regulation of clock genes might be extended to diverse human cell lines.
MAX-inhibition of the core clock genes is independent from CRY-mediated repression, but requires a functional E-box responsive element
The effect of MAX silencing on the transcription of clock genes resembles the molecular phenotype observed in cells or tissues lacking CRYs repressor proteins (i.e. transcriptional de-repression of CLOCK/BMAL1/CRYs targets) (Kondratov et al., 2006; Takahashi, 2017) .
We thus investigated whether MAX might affect CRY-mediated repression by evaluating the expression of PER1 and PER2 following treatment with a CRY agonist (KL001 (Hirota et al., 2012) ) in MDA-MB-231 knocked down for BMAL1 or MAX. As expected, KL001 augmented CRY transcriptional repression in control cells, as indicated by the significant decrease of PER1 and PER2 mRNA levels in KL001 treated cells compared with vehicle ( Fig. 2A and B ). In line with the essential role of CLOCK/BMAL1 complex in mediating CRY1 activity (Takahashi, 2017) , the knockdown of BMAL1 strongly reduced KL001mediated inhibition of PER1 and PER2 transcription.
In contrast, KL001 efficacy was preserved upon MAX knocked down, as indicated by a comparable drug-related decrease in PER transcripts in both MAX-silenced and control cells ( Fig. 2A and B ). In addition, MAX silencing significantly enhanced the transcription of PER1, PER2, CRY2, and TEF in both control and CRY1-silenced cells ( Fig. S2A ).
Collectively, our results suggest that MAX repression operates independently from the activity of the BMAL1/CLOCK/CRY repressor complex.
The above results do not preclude the possibility that BMAL1 and MAX might regulate the expression of clock target genes by acting on similar regulatory regions. Indeed, both these transcription factors interact with E-box and E-box-like elements (Hardin, 2004; Lüscher, 2001) . To evaluate this aspect, we generated two transgenic MDA-MB-231 cell lines expressing the Green Fluorescent Protein (GFP) gene under the control of a promoter fragment of PER2 containing either a wild-type or a mutated E'-box element (E'box-GFP and E' mut -box-GFP cells, respectively) ( Fig. 2C ). Indicating a functional clock regulation of our cell-based reporter system, KL001 reduced the expression of GFP in E'box-GFP, but not in E' mut -box-GFP cells (Fig. S2B ). As an internal control, KL001 treatment inhibited the transcription of the endogenous PER2 gene in both cell lines.
We thus evaluated the effect of BMAL1 or MAX silencing in the GFP reporter cells.
Revealing that both factors require a functional E'-box for their transcriptional activity, the knockdown of either BMAL1 or MAX reduced GFP expression in E'-box-GFP, but not in E'-box . In contrast, endogenous PER2 transcription was elevated in both cell lines upon silencing of either BMAL1 or MAX.
MAX is recruited on BMAL1 bound genomic regions in a MYC-independent manner
Our results with the GFP-reporter cell lines suggest that BMAL1 and MAX might be recruited on the same E-box containing regulatory regions within the promoters of clock target genes. To explore this possibility, we performed Chromatin Immuno-Precipitation sequencing (ChIP-seq) experiments with specific antibodies against BMAL1 and MAX proteins. This analysis revealed a large number of genomic regions bound by MAX (around 13000 peaks), while BMAL1 binding was limited to about 800 regions ( Fig. 3A , Table S1 and S2). BMAL1 and MAX bound regions comprised both promoters and distal sites. Coherently with the circadian role of BMAL1 and its preference for E-box-containing sites, ontological annotation of BMAL1 bound regions showed a significant enrichment for circadian regulated genes and E-box motifs (Fig. S3A ). Remarkably, 85% of the BMAL1 bound sites overlapped with MAX bound regions ( Fig. 3B, C) . Furthermore, the enrichment of MAX was significantly higher on the genomic regions bound by BMAL1 than on the loci sites in which BMAL1 was not present (Fig. 3D ), thus indicating that BMAL1 target sites are bound by MAX with high affinity.
Strikingly, MAX was present on the promoters of all the E-box-containing circadian factors up regulated upon MAX silencing (PER1, PER2, CRY1, CRY2, and TEF) ( Fig. 3E ), supporting a direct transcriptional repressive activity of MAX on the clock molecular machinery.
While MAX was not detected on the BMAL1 locus ( Fig. 3E ), we observed an enrichment of MAX on the promoters of NR1D1 and NR1D2 ( Fig. S3B ), which form a well-established feedback loop with BMAL1 in the circadian signalling network (Takahashi, 2017) . It is thus conceivable that transcriptional de-repression of NR1D1/NR1D2 in MAX-silenced MDA-MB-231 was not observed because of the resulting compensatory lowering in BMAL1 levels (Fig. 1C ). Consistent with this hypothesis, the knockdown of MAX in BMAL1silenced cells significantly increased both NR1D1 and NR1D2 transcription ( Fig. S3C ).
We further evaluated whether the recruitment of MAX on BMAL1 target promoters might be independent from MYC by immunoprecipitation of MYC-silenced and control chromatin samples with an anti-MAX antibody. Strikingly, MYC silencing resulted in negligible differences in the enrichment of MAX on the promoters of PER2, CRY1 and CRY2 (Fig.   3F ). Confirming the actual reduction of MYC in MYC-silenced cells, ChIP with an anti-MYC antibody showed a drastic reduction of MYC recruitment on the NCL promoter in cells knocked down for MYC, compared with control ( Fig. 3G ).
Altogether, our data reveal that MAX can operate as a direct repressor of core clock genes in a MYC-independent manner.
MAX and BMAL1 regulates the expression of common transcripts
Genome wide co-occurrence of BMAL1 and MAX on transcriptional regulatory regions suggest that these proteins might control the expression of common targets. To address this, we used a next generation sequencing (NGS) approach for the identification of differentially expressed genes (DEGs) in MAX-or BMAL1-silenced MDA-MB-231 cells.
Transcript assembly and quantification of RNA-sequencing reads identified 4863 and 4247 differentially expressed genes (DEGs) upon knockdown of either BMAL1 or MAX, respectively (Supplemental Table 3 -4) . The comparison of the two sets of genes revealed that 2391 of siBMAL1 DEGs (almost 50%) were also differentially expressed in MAXsilenced cells ( Fig. 4A and Supplemental Table 5 ). Within this subset, 662 transcripts showed a logarithmic fold change (LogFC) greater than 0.5. We thus analysed their cooccurrence in KEGG pathways for evaluating the transcriptional signalling more affected by both MAX and BMAL1 using a false discovery rate (FDR) q value < 0.01 as a cut-off.
Strikingly, this analysis identified the circadian rhythm as a highly significant pathway (q<0.00001), together with focal adhesion and glycosaminoglycan degradation ( Fig. 4B ).
Consistent with our quantitative RT-PCR experiments, the list of transcripts co-regulated by MAX and BMAL1 included period and cryptochrome circadian repressor genes (Supplemental Table 5 ). In addition, another negative regulator of BMAL1/CLOCKmediated transcription, BHLHE41 (also known as DEC2) (Honma et al., 2002) , resulted under the control of both MAX and BMAL1.
Notably, heat map and clustering analysis of DEGs in siMAX and siBMAL1 cells revealed that more than 90% of these genes (2241 out of 2391) were coherently altered in both conditions (i.e. their expression was altered in the same direction upon either MAX or BMAL1 silencing) ( Fig. 4C ). These results suggest that the overall effect of a reduction of MAX in silenced cells is a derepression of genes that are negatively regulated by the Collectively, our data indicate that MAX is part of the negative arm of the molecular clock machinery.
MAX is required for circadian gene expression
The above results strongly suggest that MAX might have a direct role in circadian transcriptional regulation, thus contributing to rhythmic oscillatory expression of clock target genes. To investigate this aspect, we silenced either BMAL1 or MAX in MDA-MB-231 cells expressing a firefly luciferase reporter controlled by the BMAL1 promoter and monitored luciferase activity with a real-time luminometer after circadian synchronization by dexamethasone treatment (Ramanathan et al., 2012) ( Fig. 5A ). Baseline-subtracted luminescence data were then fitted to a sine wave and plotted to compare rhythmic patterns ( Fig. 5B ). This analysis showed a rhythmic oscillation of luminescence in dexamethasone-treated control cells over a 72 h period. Confirming that this rhythm was under the control of the circadian clock machinery, knockdown of BMAL1 prevented the oscillation of the luciferase reporter. Strikingly, silencing of MAX markedly reduced rhythm amplitude compared with control cells (Fig. 5B ).
We then analyzed the circadian profile of different endogenous clock genes in BMAL1 and MAX-silenced cells synchronized by dexamethasone treatment. In line with observations in liver from Bmal1 -/mice (Hatanaka et al., 2010; Kondratov et al., 2006) , knockdown of BMAL1 prevented time-dependent variations of all circadian transcripts ( Fig. 5C ).
Consistent with our luminescence analysis, MAX-silenced cells showed a reduced BMAL1 oscillatory expression compared with control cells. Furthermore, reduction of MAX altered the expression of all circadian genes analyzed ( Fig. 5C ). Of note, PER1, PER2 and CRY1 transcript levels were constitutively higher at all time-points in MAX-silenced cells, which is consistent with their elevated expression in non-synchronous cells upon knockdown of
MAX.
These results show that MAX is an essential regulator of circadian gene expression in MDA-MB-231 cells.
Cancer cell lines are associated with many mutations (Barretina et al., 2012) , which might alter the activity and specificity of transcription factors. We thus evaluated whether MAX could control clock gene transcription in two non-cancerous human cell lines, foreskin fibroblast BJ-5ta and epithelial MCF10A. Similar to our observations in diverse cancer cells lines ( Fig. 1F) , MAX silencing increased the levels of clock transcripts in both BJ-5ta and MCF10A ( Fig. 6A and B ). Quantitative ChIP assays with an anti-MAX antibody further revealed that MAX-mediated clock gene expression in MCF10A also corresponded with a direct recruitment of MAX on the promoter of those circadian genes ( Fig. 6C ). Moreover, MAX silencing in BMAL1-luc MCF10A cells markedly reduced the amplitude of luciferase oscillation following dexamethasone synchronization treatment compared with control ( Fig.   6D ).
Collectively, our data support an essential function of MAX in regulating the circadian clock of both cancer and non-cancerous cells.
MAX dependent repression of clock genes requires MNT
MAX can operate as either an activator or a repressor of transcription depending on the interacting partner proteins (Kretzner et al., 1992; Nair and Burley, 2003) . Among these protein complexes, those formed by MAX and MNT actively repress the expression of genes containing E-box elements in their regulatory regions (Terragni et al., 2011) .
Suggesting a role of MNT in MAX-mediated clock transcription, PER2 protein levels increased upon the knockdown of either MAX or MNT in MDA-MB-231 cells ( Fig. 7A and   B ).
We then evaluated the transcription of PER2, CRY1, and CRY2 in MDA-MB-231 cells knocked down for MAX, MNT or both proteins. Consistent with our immunoblot analysis, MNT expression significantly increased in MAX-silenced cells ( Fig. 7C ). Strikingly, MAX reduction in siMAX/siMNT cells did not further alter the de-repression of clock genes observed with the single knockdown of MNT, indicating that a repressive complex formed by MAX and MNT regulates clock gene expression. Supporting this hypothesis, ChIP analysis in MAX-silenced MDA-MB-231 cells with an anti-MNT antibody revealed a MAXmediated recruitment of MNT on PER2, CRY1 and CRY2 promoters ( Fig. 7D ). Notably, immunoprecipitation from the same MAX-silenced chromatin samples with an anti-MYC antibody revealed that the remaining MAX protein was still sufficient for a substantial binding of MYC on the promoter of NCL ( Fig. 7E ), which is consistent with the fact that MAX reduction did not affect MYC dependent transcription in MDA-MB-231 cells.
Similar to MAX silencing, knockdown of MNT in BMAL1-luc MDA-MB-231 cells markedly reduced luciferase oscillation after dexamethasone synchronization ( Fig. 7F ), further supporting a fundamental role of MNT in MAX-dependent clock regulation.
Indicating that this MNT function was not limited to breast cancer MDA-MB-231, MCF10A cells knocked down for MNT showed increased expression of PER1, PER2, CRY1, CRY2, and impaired oscillation of the luciferase circadian reporter (Fig. S4 ).
Discussion
Our knockdown experiments indicate that MAX regulates the transcription of diverse genes belonging to the core clock machinery in both cancer and non-cancerous cell lines.
Remarkably, knockdown of MAX was not sufficient to affect both the transcription of cell cycle-related MYC targets and MDA-MB-231 proliferation. Suggesting that the residual MAX protein still allowed for a MYC-dependent transcription of cell cycle genes, the recruitment of MYC on NCL promoter was not significantly reduced in MAX-silenced cells.
These data imply that MAX-mediated activity on clock genes is independent from the role of MAX as a MYC-associated factor. Supporting this concept, the knockdown of MYC produced negligible effects on the expression of core clock genes and it did not alter the recruitment of MAX on PER2, CRY1 and CRY2 promoters.
MAX actively represses numerous core clock genes by its direct binding to E-box containing regions, as indicated by our ChIP-seq and qChIP analyses and by a lack of MAX-mediated derepression of a PER2 promoter bearing a mutated E'-box sequence. Our genome-wide approaches further revealed that a reduction of MAX levels affects numerous BMAL1 regulated genes. Notably, the core clock genes directly targeted and repressed by MAX include all the repressors belonging to both the primary (CRYs and PERs) and the accessory (NR1D1 and NR1D2) negative circadian feedback loops (Lee et al., 2011; Takahashi, 2017) .
Consequently, knockdown of MAX strongly altered the ratio between positive and negative elements of the molecular clock machinery in diverse cell lines. A proper stoichiometric balance between activators and repressors of E-boxes has been proposed as a crucial requirement for generating circadian rhythms (Kim and Forger, 2012; Lee et al., 2011) .
Accordingly, MAX silencing impaired rhythmic gene expression in both MDA-MB-231 and MCF10A cells, indicating an essential role of MAX in maintaining a functional circadian rhythm.
Collectively, our data support a model in which MAX is an essential part of the molecular clock and keeps the balance between clock activators and repressors.
We also identified MNT as a partner in MAX-mediated circadian regulation that is recruited on the promoters of clock core genes in a MAX-dependent manner. 
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Method Details
Cell culture
Human breast cancer MDA-MB-231, BT549, human skin cancer A375, human stomach cancer SNU16, human embryonic kidney HEK-293 and HEK-293T cell lines (previously obtained from American Type Culture Collection (ATCC)) were grown in DMEM medium All cell lines were maintained at 37 °C in a humidified atmosphere with 5% CO 2 .
siRNA transfection
For RNAi experiments, 30 nM siRNA sequences against MAX, MYC, BMAL1, CRY1, CRY2, and MNT were reverse-transfected with DharmaFect 1 Transfection reagent (Dharmacon, catalog#T-2001-03) following the manufacturer's protocol. As a control, cells were transfected with MISSION® siRNA Universal Negative Control #1 (Sigma, catalog#SIC001).
Cell proliferation analysis
MDA-MB-231 cells were transfected with siRNA sequence against BMAL1, MAX, MYC or a non-coding control. The number of cells was counted 24, 48, 72 and 96 hours after transfection with a Countess II FL (Life Technologies). Trypan blue staining was used to discriminate live and dead cells.
Quantitative RT-PCR
RNA and cDNA samples were prepared by Trizol (Life Technologies, catalog#15596018) extraction and retro-transcription with SuperScript ViloTM Master Mix (Invitrogen, catalog#11755-250) following the manufacturer's protocol. Relative transcript expression levels were assessed by quantitative PCR with iTaqTM Universal SYBR Green Supermix (BioRad, catalog#172-5124) on a Via7 thermocycler (Invitrogen). GAPDH transcripts were used for normalization. Primer sequences are listed in Supplemental Table 6 .
RNA sequencing
Total RNA samples were prepared by Trizol extraction followed by purification with PureLink RNA kit (Invitrogen, catalog#12183018A). RNA integrity was examined using Supplemental Table S6 .
Promoter occupancy was calculated as percent of input using the following formula: [2^-
Chromatin immunoprecipitation sequencing
For ChIP sequencing, immunoprecipitated DNA from MDA-MB-231 chromatin samples was obtained with the protocol described for quantitavie ChIP. Input and immunoprecipitated DNA (1-10 ng) were blunt-ended and phosphorylated, and a single 'A'
nucleotide was added to the 3' ends of the fragments in preparation for ligation to an adapter that has a single-base 'T' overhang. The ligation products was purified and accurately size-selected by agencourt AMPure XP beads (Beckman Coulter, catalog# A63881). Purified DNA was PCR-amplified to enrich for fragments that have adapters on both ends. All the steps were performed on automation instrument, Biomek FX by 
Immunoblotting
Protein samples were extracted in RIPA buffer as described previously (De Mei et al., 2015) . Immunoblot were performed on 20 µg of protein extracts separated on 8-15% 
Generation of PER2 promoter reporter plasmids
Sequencing Data availability
The datasets and computer code produced in this study are available at Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE127192), accession numbers GSE127192 and GSE127212.
Statistical Analysis
For qRT-PCR, qChIP and cell proliferation analyses, statistical significance between groups was calculated by two-way ANOVA associated with Bonferroni post-tests. The correlation between BMAL1/MAX-bound DEGs genes was evluated using Spearman's rank correlation test. These statistical analyses were performed using Prism6 software package. Significance values were P < 0.05 (*), P < 0.01 (**) and P < 0.001 (*** Shown as mean ± SEM, n = 3.
See also related Supplemental Figure S1 . See also related Supplemental Figure S3 and Table S1-S2. 
